The disclosure is directed to methods of using TUDCA, or a pharmaceutically acceptable salt thereof, or a derivative thereof, for the treatment of SARS-CoV-2 infections.
本公开涉及使用 TUDCA 或其药学上可接受的盐或其衍生物治疗 SARS-CoV-2 感染的方法。
COMPOUND, ACTIVE LIGHT SENSITIVE OR RADIATION SENSITIVE RESIN COMPOSITION, RESIST FILM USING SAME, RESIST-COATED MASK BLANK, PHOTOMASK, PATTERN FORMING METHOD, METHOD FOR MANUFACTURING ELECTRONIC DEVICE, AND ELECTRONIC DEVICE
申请人:FUJIFILM Corporation
公开号:US20160116840A1
公开(公告)日:2016-04-28
Provided is an active light sensitive or radiation sensitive resin composition which contains a compound (A) represented by General Formula (I) or (II):
in the formulae, each of Y
1
and Y
2
represents a monovalent organic group; each of M
1
+
and M
2
+
represents an organic onium ion; each of X
1
and X
2
represents a group that is represented by —S—, —NH—, or —NR
1
—; R
1
represents a monovalent organic group; each of n1 and n2 represents an integer of 1 or more; and R
1
and Y
1
or Y
2
may bond with each other to form a ring.
METHODS OF TREATING SARS-COV-2 INFECTIONS
申请人:Tyme, Inc.
公开号:US20210353645A1
公开(公告)日:2021-11-18
The disclosure is directed to methods of using TUDCA, or a pharmaceutically acceptable salt thereof, or a derivative thereof, for the treatment of SARS-CoV-2 infections.
US9904167B2
申请人:——
公开号:US9904167B2
公开(公告)日:2018-02-27
[EN] METHODS OF USING BILE ACIDS TO TREAT VIRAL INFECTIONS<br/>[FR] MÉTHODES D'UTILISATION D'ACIDES BILIAIRES POUR TRAITER DES INFECTIONS VIRALES
申请人:HOFFMAN STEVEN
公开号:WO2021231934A1
公开(公告)日:2021-11-18
The disclosure is directed to methods of using hydrophilic bile acids for the treatment of viral infections.